Detalhe da pesquisa
1.
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer.
Mol Cancer
; 23(1): 61, 2024 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38519913
2.
A software tool to support follow-up care in a French childhood cancer cohort: construction and feasibility.
BMC Cancer
; 24(1): 130, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267891
3.
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Lancet
; 399(10336): 1695-1707, 2022 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405085
4.
Stereotactic body radiation therapy after radical prostatectomy: current status and future directions.
World J Urol
; 41(11): 3333-3344, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725131
5.
Post-operative flank irradiation using conformal versus highly conformal radiotherapy techniques for paediatric renal tumours: Results from the French registry PediaRT.
Pediatr Blood Cancer
; 70(11): e30627, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580901
6.
Locoregional failure after postoperative flank irradiation for nephroblastoma: Results from the French cohort of the SIOP-2001 trial.
Pediatr Blood Cancer
; 69(12): e29950, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36057861
7.
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.
Lancet Oncol
; 21(10): 1341-1352, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002438
8.
microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation.
Mol Cancer
; 19(1): 63, 2020 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32293453
9.
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Lancet Oncol
; 20(12): 1740-1749, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629656
10.
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging.
BMC Cancer
; 19(1): 167, 2019 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30791889
11.
Meta-analysis of predictive models to assess the clinical validity and utility for patient-centered medical decision making: application to the CAncer of the Prostate Risk Assessment (CAPRA).
BMC Med Inform Decis Mak
; 19(1): 2, 2019 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30616621
12.
A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients.
Health Qual Life Outcomes
; 16(1): 40, 2018 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29506537
13.
Treatment of cutaneous and/or soft tissue manifestations of corticosteroids refractory chronic graft versus host disease (cGVHD) by a total nodal irradiation (TNI).
Clin Transplant
; 31(4)2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28181304
14.
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Lancet Oncol
; 17(6): 747-756, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27160475
15.
OLIGOPELVIS - GETUG P07: a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer.
BMC Cancer
; 15: 646, 2015 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26408012
16.
Salvage prostate intensity modulated radiation therapy after cryotherapy failure.
Sci Rep
; 14(1): 9148, 2024 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38644367
17.
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
Clin Transl Radiat Oncol
; 44: 100702, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111609
18.
Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07).
Eur Urol
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490854
19.
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial.
Eur Urol Oncol
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734543
20.
How to contour the different heart subregions for future deep-learning modeling of the heart: A practical pictorial proposal for radiation oncologists.
Clin Transl Radiat Oncol
; 45: 100718, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38204729